KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Current Deferred Revenue (2019 - 2025)

Historic Current Deferred Revenue for Ginkgo Bioworks Holdings (DNA) over the last 7 years, with Q3 2025 value amounting to $25.2 million.

  • Ginkgo Bioworks Holdings' Current Deferred Revenue rose 1022.98% to $25.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.2 million, marking a year-over-year increase of 1022.98%. This contributed to the annual value of $126.5 million for FY2024, which is 3753.09% down from last year.
  • Ginkgo Bioworks Holdings' Current Deferred Revenue amounted to $25.2 million in Q3 2025, which was up 1022.98% from $28.3 million recorded in Q2 2025.
  • Ginkgo Bioworks Holdings' Current Deferred Revenue's 5-year high stood at $222.6 million during Q4 2022, with a 5-year trough of $22.9 million in Q3 2024.
  • Over the past 5 years, Ginkgo Bioworks Holdings' median Current Deferred Revenue value was $126.5 million (recorded in 2024), while the average stood at $99.5 million.
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first surged by 9450000.0% in 2021, then crashed by 8055.97% in 2024.
  • Ginkgo Bioworks Holdings' Current Deferred Revenue (Quarter) stood at $189.2 million in 2021, then rose by 17.65% to $222.6 million in 2022, then decreased by 9.03% to $202.5 million in 2023, then plummeted by 37.53% to $126.5 million in 2024, then crashed by 80.05% to $25.2 million in 2025.
  • Its last three reported values are $25.2 million in Q3 2025, $28.3 million for Q2 2025, and $33.7 million during Q1 2025.